Why the study?
Can subcutaneous enoxaparin be used for outpatient anticoagulation therapy in a patient with a mechanical aortic valve replacement and subtherapeutic INR on warfarin?
Population
1 patient with a mechanical aortic valve replacement who underwent elective transurethral prostatectomy and…
Comparison
Enoxaparin 1 mg/kg subcutaneously every 12 hours vs null
Design
Case_report
Authors
Loading...
Enoxaparin may enable outpatient anticoagulation in select mechanical valve patients with subtherapeutic INR; this case report leaves open the need for prospective trials.
Can subcutaneous enoxaparin be used for outpatient anticoagulation therapy in a patient with a mechanical aortic valve replacement and subtherapeutic INR on warfarin?
Subcutaneous enoxaparin may be a safe and cost-effective bridge for outpatient anticoagulation in patients with mechanical heart valves who have difficulty achieving therapeutic INR on warfarin.
Manley et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: